132 related articles for article (PubMed ID: 11023935)
1. Effects of antihypertensive therapy on glucose and insulin metabolism and on left ventricular mass: A randomized, double-blind, controlled study of 21 obese hypertensives.
Kuperstein R; Sasson Z
Circulation; 2000 Oct; 102(15):1802-6. PubMed ID: 11023935
[TBL] [Abstract][Full Text] [Related]
2. Effects of antihypertensive therapy on glucose, insulin metabolism, left ventricular diastolic dysfunction and renin system in overweight and obese hypertensives.
De Rosa ML; Musella F; Ilardi F; D'Amore C; Luciano R; Maresca F
J Renin Angiotensin Aldosterone Syst; 2014 Jun; 15(2):196-204. PubMed ID: 23396551
[TBL] [Abstract][Full Text] [Related]
3. Regression of left ventricular mass in hypertensive patients treated with perindopril/indapamide as a first-line combination: the REASON echocardiography study.
de Luca N; Mallion JM; O'Rourke MF; O'Brien E; Rahn KH; Trimarco B; Romero R; De Leeuw PW; Hitzenberger G; Battegay E; Duprez D; Sever P; Safar ME
Am J Hypertens; 2004 Aug; 17(8):660-7. PubMed ID: 15323062
[TBL] [Abstract][Full Text] [Related]
4. Glucose and insulin metabolism are important determinants of left ventricular mass in obese hypertensives.
Kuperstein R; Sasson Z
Can J Cardiol; 2000 Sep; 16(9):1103-8. PubMed ID: 11021954
[TBL] [Abstract][Full Text] [Related]
5. Effect of bunazosin and atenolol on glucose metabolism in obese, nondiabetic patients with primary hypertension.
Bönner G; Schmieder R; Chrosch R; Weidinger G
Cardiovasc Drugs Ther; 1997 Mar; 11(1):21-6. PubMed ID: 9140673
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus.
Derosa G; Cicero AF; Ciccarelli L; Fogari R
Clin Ther; 2003 Jul; 25(7):2006-21. PubMed ID: 12946547
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
Giugliano D; Acampora R; Marfella R; De Rosa N; Ziccardi P; Ragone R; De Angelis L; D'Onofrio F
Ann Intern Med; 1997 Jun; 126(12):955-9. PubMed ID: 9182472
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
9. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects.
de Luca N; Asmar RG; London GM; O'Rourke MF; Safar ME;
J Hypertens; 2004 Aug; 22(8):1623-30. PubMed ID: 15257187
[TBL] [Abstract][Full Text] [Related]
10. Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.
Schneider MP; Klingbeil AU; Delles C; Ludwig M; Kolloch RE; Krekler M; Stumpe KO; Schmieder RE
Hypertension; 2004 Jul; 44(1):61-6. PubMed ID: 15184349
[TBL] [Abstract][Full Text] [Related]
11. Correction of hypertensive cardiac remodelling: comparison of different antihypertensive therapies.
Almazov VA; Shlyakhto EV; Konrady AO; Macsimova TA; Zaharov DV; Rudomanov OG
Med Sci Monit; 2000; 6(2):309-13. PubMed ID: 11208328
[TBL] [Abstract][Full Text] [Related]
12. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension.
Buus NH; Bøttcher M; Jørgensen CG; Christensen KL; Thygesen K; Nielsen TT; Mulvany MJ
Hypertension; 2004 Oct; 44(4):465-70. PubMed ID: 15326083
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of doxazosin and atenolol on target organ damage in adults with type 2 diabetes mellitus and hypertension in the CARDHIAC study: a 9-month, prospective, randomized, open-label, blinded-evaluation trial.
Barrios V; Escobar C; Tomás JP; Calderon A; Echarri R
Clin Ther; 2008 Jan; 30(1):98-107. PubMed ID: 18343246
[TBL] [Abstract][Full Text] [Related]
14. Metabolic neutrality of perindopril: focus on insulin sensitivity in overweight patients with essential hypertension.
Böhlen L; Bienz R; Doser M; Papiri M; Shaw S; Riesen W; Weidmann P
J Cardiovasc Pharmacol; 1996 Jun; 27(6):770-6. PubMed ID: 8761842
[TBL] [Abstract][Full Text] [Related]
15. Nitrendipine and atenolol in essential hypertension in young and middle-aged patients: effect on serum lipids and left ventricular mass.
López NC; Corral JL; Rincón LA; Arreaza MR; Giralt J; Galué GA; Barrios YE; Arocha I
J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S101-5. PubMed ID: 1723446
[TBL] [Abstract][Full Text] [Related]
16. [Echocardiography of left ventricular mass in patients with essential hypertension].
Christensen KL; Fenger-Grøn M; Buus NH
Ugeskr Laeger; 2009 Nov; 171(45):3252-5. PubMed ID: 19887054
[TBL] [Abstract][Full Text] [Related]
17. Effects of sympatholytic therapy on insulin sensitivity indices in hypertensive postmenopausal women.
Kaaja R; Kujala S; Manhem K; Katzman P; Kibarskis A; Antikainen R; Ylihärsilä H; Erkkola R; Tuomilehto J
Int J Clin Pharmacol Ther; 2007 Jul; 45(7):394-401. PubMed ID: 17725246
[TBL] [Abstract][Full Text] [Related]
18. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients.
Bang CN; Gerdts E; Aurigemma GP; Boman K; de Simone G; Dahlöf B; Køber L; Wachtell K; Devereux RB
Circ Cardiovasc Imaging; 2014 May; 7(3):422-9. PubMed ID: 24723582
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive Effect and Tolerability of Perindopril in Indian Hypertensive and Type 2 Diabetic Patients: 1-Year Randomised, Double-Blind, Parallel Study vs Atenolol.
Seedat YK; Randeree IG
Clin Drug Investig; 1998; 16(3):229-40. PubMed ID: 18370544
[TBL] [Abstract][Full Text] [Related]
20. Effect of dual blockade of renin-angiotensin system on TGFbeta1 and left ventricular structure and function in hypertensive patients.
Scaglione R; Argano C; Di Chiara T; Parrinello G; Colomba D; Avellone G; Donatelli M; Corrao S; Licata G
J Hum Hypertens; 2007 Apr; 21(4):307-15. PubMed ID: 17301824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]